Gene: COQ10B
Official Full Name: coenzyme Q10Bprovided by HGNC
Gene Summary: Predicted to enable ubiquinone binding activity. Predicted to be involved in cellular respiration. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26116 | COQ10B Knockout cell line (HeLa) | Human | COQ10B | 1:3~1:6 | Negative | Online Inquiry |
KO26117 | COQ10B Knockout cell line (HCT 116) | Human | COQ10B | 1:2~1:4 | Negative | Online Inquiry |
KO26118 | COQ10B Knockout cell line (HEK293) | Human | COQ10B | 1:3~1:6 | Negative | Online Inquiry |
KO26119 | COQ10B Knockout cell line (A549) | Human | COQ10B | 1:3~1:4 | Negative | Online Inquiry |
COQ10B Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the functional COQ10B gene, which is essential in the biosynthetic pathway of coenzyme Q10 (CoQ10). CoQ10 is a critical cofactor involved in mitochondrial energy production and oxidative phosphorylation. Its absence in these cell lines allows researchers to investigate the role of COQ10B in cellular metabolism, energy production, and associated metabolic disorders without the interference of the wild-type gene's activity.
The key functions of COQ10B Gene Knockout Cell Lines reside in their ability to serve as a powerful model for studying the effects of CoQ10 deficiency on cellular processes, including apoptosis, oxidative stress response, and mitochondrial dysfunction. By elucidating the mechanisms underlying these pathways, researchers can gain insights into various conditions such as cardiovascular diseases, neurodegenerative disorders, and myopathies where CoQ10 plays a crucial therapeutic role.
In clinical settings, the application of these knockout cell lines extends to drug development and testing, allowing for the assessment of therapeutic compounds aimed at alleviating symptoms associated with CoQ10 deficiency. Compared to traditional cellular models, our COQ10B Gene Knockout Cell Lines provide a more accurate representation of the disease state, thereby enhancing the translational potential of research findings.
One of the notable advantages of our product over competitors is the precision and reliability in genome editing that ensures complete absence of COQ10B activity, thus minimizing background effects. Our offering comes supported by comprehensive technical documentation and a team of experts ready to assist users in experimental design and data interpretation, ensuring that researchers can maximize the utility of these cell lines.
The value of COQ10B Gene Knockout Cell Lines lies not only in their scientific applications but also in their capacity to facilitate advancements in understanding mitochondrial biology and related pathologies. At [Your Company], we pride ourselves on delivering cutting-edge biological tools, backed by extensive research and development expertise, to empower researchers and clinicians in their quest for discovery and innovation in health science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.